Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults

ClinicalTrials.gov ID: NCT04625972

Public ClinicalTrials.gov record NCT04625972. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 8:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442, a Combination Product of Two Monoclonal Antibodies (AZD8895 and AZD1061), for Post-exposure Prophylaxis of COVID-19

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will assess the efficacy of AZD7442 for the post-exposure prophylaxis of COVID-19 in Adults.

Study identification

NCT ID
NCT04625972
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
1,131 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2, 2020 (Actual)
Primary completion
Apr 7, 2021 (Actual)
Completion
Jul 25, 2022 (Actual)
Last update posted
Nov 21, 2023

2020 – 2022

United States locations

U.S. sites
50
U.S. states
18
U.S. cities
45
Facility City State ZIP Site status
Research Site Guntersville Alabama 35976 —
Research Site Tempe Arizona 85284 —
Research Site Little Rock Arkansas 72205 —
Research Site Bakersfield California 93309 —
Research Site Corona California 92882 —
Research Site Garden Grove California 92844 —
Research Site Huntington Beach California 92647 —
Research Site Huntington Park California 90255 —
Research Site Modesto California 95350 —
Research Site Coral Gables Florida 33134 —
Research Site Coral Springs Florida 33071 —
Research Site Miami Florida 33125 —
Research Site Miami Florida 33155 —
Research Site Miami Florida 33175 —
Research Site Miami Florida 33256 —
Research Site Miami Lakes Florida 33014 —
Research Site Miami Lakes Florida 33016 —
Research Site Miami Springs Florida 33166 —
Research Site Mt. Dora Florida 32757 —
Research Site North Miami Florida 33161 —
Research Site Pembroke Pines Florida 33024 —
Research Site Pompano Beach Florida 33064 —
Research Site Tampa Florida 33603 —
Research Site West Palm Beach Florida 33409 —
Research Site Atlanta Georgia 30328 —
Research Site Buford Georgia 30519 —
Research Site Conyers Georgia 30094 —
Research Site Chicago Illinois 60607 —
Research Site Chicago Illinois 60640 —
Research Site Hazel Crest Illinois 60429-2196 —
Research Site Noblesville Indiana 46060 —
Research Site West Des Moines Iowa 50266 —
Research Site Wichita Kansas 67205 —
Research Site Owensboro Kentucky 42303 —
Research Site Bethesda Maryland 20814 —
Research Site High Point North Carolina 27262 —
Research Site Wilmington North Carolina 28401 —
Research Site Orangeburg South Carolina 29118 —
Research Site Dallas Texas 75235 —
Research Site El Paso Texas 79930 —
Research Site Friendswood Texas 77546 —
Research Site Gonzales Texas 78629 —
Research Site Harlingen Texas 78550 —
Research Site Houston Texas 77099 —
Research Site San Antonio Texas 78215 —
Research Site Riverton Utah 84096 —
Research Site Alexandria Virginia 22311 —
Research Site Portsmouth Virginia 23708 —
Research Site Richmond Virginia 23226 —
Research Site Tacoma Washington 98402 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04625972, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 21, 2023 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04625972 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →